Partner
Alison Leroy
Presentation
Before joining UGGC Avocats, Alison Leroy worked for 7 years at Carakters, then at Franklin from 2020, and recently at Bersay, where she opened the “Life Sciences, Biotech and Pharma R&D” department. She has developed solid expertise in preventive risk management and support for industrial and real estate projects, particularly in the pharmaceutical sector.
UGGC & me
What led me to join UGGC was the conviction that intellectual property and digital technologies – which lie at the heart of the life sciences sector – deserve an approach that is as rigorous as it is creative. Here, I have found a firm where technical excellence is combined with a genuine culture of client service, with multidisciplinary teams capable of supporting both a biotech start-up in building its patent portfolio and a major pharmaceutical group in its licensing or litigation matters. What I deeply appreciate about UGGC is the intellectual freedom that is fostered here: the freedom to defend bold positions, to anticipate regulatory and technological developments, and to build bespoke IP strategies, designed for every stage of a product or technology’s lifecycle.
My practice
My work focuses on two complementary areas: strategic advice and litigation, at the intersection of intellectual property law, technology law and regulatory issues specific to the life sciences.
In my advisory work, I assist pharmaceutical companies, biotech and medtech start-ups, digital health groups and their investors in structuring and managing their IP portfolios: patent strategy, protection of know-how and data, licensing and technology transfer agreements, IP due diligence in the context of mergers and acquisitions, and regulatory compliance (GDPR, cybersecurity, AI Act).
In litigation, I defend my clients’ interests before French and European courts in disputes relating to patent infringement, unfair competition, the protection of trade secrets, data rights and liabilities arising from artificial intelligence.
My sector expertise includes, in particular:
- Brand-name medicines and generics/biosimilars (pharmaceutical patent litigation)
- Connected medical devices and digital health (healthcare SaaS, diagnostic AI, telemedicine)
- Biotechnology and genomics (sequence protection, health data, R&D agreements)
- Information technology applied to healthcare (cybersecurity, cloud computing, interoperability)
Careers and professional distinctions
2024
Partner, UGGC Avocats
2023-2024
Partner, Bersay
2020-2023
Associate, Franklin Société d’avocats
2013-2020
- Associate, Carakters
- HEDA Haute Ecole des Avocats Conseils des Barreaux du ressort de la Cour d’appel de Versailles (Versailles Court of Appeal Lawyers’ Training College)
- Master of Law, Université Côte d’Azur
- Master of Business Law, Université Paris-Sud
